Significance of Streptozotocin
Streptozotocin is a chemical compound utilized in experimental settings to induce diabetes in laboratory animals by damaging pancreatic beta cells. It is frequently administered to rats and can also be used in other animals, such as rabbits, for research purposes. This compound is noted for its selective toxicity to insulin-producing cells in the pancreas, enabling researchers to create diabetic models for studying antidiabetic interventions and the effects of treatments on diabetic complications.
The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.
The concept of Streptozotocin in scientific sources
Streptozotocin is a chemical compound employed in research to induce diabetes in rats by selectively damaging insulin-producing beta cells, making it a crucial tool for studying diabetes in animal models.
From: The Malaysian Journal of Medical Sciences
(1) This substance was used in combination with nicotinamide to induce micronuclei formation in the experimental setup involving rats.[1] (2) This is a diabetogenic factor with cytotoxic effects on pancreatic beta cells, which was used to induce diabetes in the mice, leading to the destruction of beta cells.[2] (3) Streptozotocin, also known as STZ, is used in the animal model of Alzheimer's disease, and its local injection at a sub-diabetogenic dose creates a similar pathology.[3] (4) A chemical used to induce diabetes in experimental animal models by destroying insulin-producing beta cells in the pancreas.[4]